Suppr超能文献

[对甲状腺激素的抵抗]

[Resistance to thyroid hormone].

作者信息

Takeda K, Hashimoto K

机构信息

Second Department of Internal Medicine, Kochi Medical School.

出版信息

Nihon Rinsho. 1994 Apr;52(4):922-8.

PMID:8196181
Abstract

Resistance to thyroid hormone (RTH), Refetoff's syndrome, is a syndrome of reduced responsiveness of target tissue to thyroid hormone (TH). Inheritance is usually autosomal dominant except in one family, being recessive. Since a point mutation was first discovered in the thyroid hormone receptor (TR) beta gene of a subject with RTH, approximately 93 unrelated families with RTH have been found to have mutations on TR beta gene. Clinically they presented either generalized (GRTH) or dominantly pituitary (PRTH) resistance to TH. In one family, affected consanguineous individuals lacked the entire protein coding region of both hTR beta alleles. In this family with recessively inherited RTH, the obligate heterozygous parents exhibited no clinical and laboratory abnormalities. Thus, manifestation of RTH in heterozygous individuals required the expression of a mutant receptor that interferes with the function of normal allele ("dominant negative effect"). The formation of mutant TR/TRAP (RXR etc.) heterodimer or mutant TR homodimer having the capability to bind the DNA for this dominant negative suppression of mutant TR beta, and the variation of TRE types, receptor isoforms and auxiliary proteins depending on the target tissue may play an important role in the manifestation of TH resistance. This may explain in part the intra- and inter-individual differences in organ resistance in patients with RTH. Studying the errors of nature would contribute to understand the molecular mechanism of TH action.

摘要

甲状腺激素抵抗(RTH),即Refetoff综合征,是一种靶组织对甲状腺激素(TH)反应性降低的综合征。除了一个家族为隐性遗传外,其遗传方式通常为常染色体显性遗传。自从在一名患有RTH的患者的甲状腺激素受体(TR)β基因中首次发现点突变以来,大约93个与RTH无关的家族被发现其TRβ基因存在突变。临床上,他们表现为全身性(GRTH)或主要为垂体性(PRTH)甲状腺激素抵抗。在一个家族中,受影响的近亲个体缺乏两个hTRβ等位基因的整个蛋白质编码区域。在这个隐性遗传RTH的家族中,必然的杂合子父母没有表现出临床和实验室异常。因此,杂合子个体中RTH的表现需要表达一种干扰正常等位基因功能的突变受体(“显性负效应”)。具有这种显性负性抑制突变TRβ能力的突变TR/TRAP(RXR等)异二聚体或突变TR同二聚体的形成,以及取决于靶组织的TRE类型、受体亚型和辅助蛋白的变化,可能在TH抵抗的表现中起重要作用。这可能部分解释了RTH患者器官抵抗的个体内和个体间差异。研究自然错误将有助于理解TH作用的分子机制。

相似文献

1
[Resistance to thyroid hormone].
Nihon Rinsho. 1994 Apr;52(4):922-8.
3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验